Large-scale testing (Phase 3)Study completedNCT01695239What this trial is testingIxekizumab in Participants With Active Psoriatic ArthritisWho this might be right forPsoriasis, Arthritic Eli Lilly and Company 417
Testing effectiveness (Phase 2)Study completedNCT00002324What this trial is testingThe Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseWho this might be right forHIV Infections Boehringer Ingelheim 250
Not applicableStudy completedNCT00002215What this trial is testingA Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveWho this might be right forHIV Infections Triangle Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00699790What this trial is testingProof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin ResistanceWho this might be right forType 2 Diabetes Bristol-Myers Squibb 58
Testing effectiveness (Phase 2)UnknownNCT05852496What this trial is testingVit D and Peripheral Neuropathy in Taxane Naive PatientsWho this might be right forVitamin D DeficiencyPeripheral Neuropathy Assiut University 60
Not applicableStudy completedNCT00002168What this trial is testingA Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsWho this might be right forHIV Infections Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Ended earlyNCT01453049What this trial is testingAn Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes PatientsWho this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 86
Post-approval studies (Phase 4)Study completedNCT01030952What this trial is testingEffects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionWho this might be right forDiabetes Mellitus, Type 2 Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)Study completedNCT00118768What this trial is testingEvaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CWho this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC 175
Testing effectiveness (Phase 2)Study completedNCT00903682What this trial is testingA Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsWho this might be right forHIV InfectionHIVAcquired Immunodeficiency Syndrome Janssen-Cilag International NV 157
Not applicableStudy completedNCT04847388What this trial is testingPrevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV AntibodiesWho this might be right forHIV Infections Singh, Ranjan Kumar, M.D. 210
Large-scale testing (Phase 3)Study completedNCT00234910What this trial is testingEfficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected PatientsWho this might be right forHIV Infection Abbott 152
Testing effectiveness (Phase 2)Ended earlyNCT00513513What this trial is testingTMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) PreviouslyWho this might be right forHIV Infections Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Active Not RecruitingNCT05917860What this trial is testingNeoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate CancerWho this might be right forLocalized Prostate CarcinomaCastration-Naive Prostate CancerIntermediate Risk Prostate Cancer+1 more Turku University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00984620What this trial is testingShort Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)Who this might be right forHepatitis C Boehringer Ingelheim 160
Testing effectiveness (Phase 2)Looking for participantsNCT06357676What this trial is testingGlofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL TrialWho this might be right forMantle Cell Lymphoma OHSU Knight Cancer Institute 27
Large-scale testing (Phase 3)Ended earlyNCT00054210What this trial is testingPolyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer CTI BioPharma
Large-scale testing (Phase 3)Study completedNCT00911287What this trial is testingOxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic PainWho this might be right forPainChronic Disease Endo USA Inc., a Keenova Therapeutics Company 129
Early research (Phase 1)Study completedNCT00503347What this trial is testingBavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusWho this might be right forHepatitis C VirusHiv Infections Peregrine Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00004578What this trial is testingABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected SubjectsWho this might be right forHIV Infections Abbott 100